Putting the Patient First: Individualized Strategies for the Treatment and Management of von Willebrand Disease

Released On
April 20, 2021

Expires On
April 20, 2022

Media Type
Internet

Completion Time
60 minutes

Specialty
Hematology-Oncology

Topic(s)
Bleeding Disorders

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Physicians’ Education Resource®, LLC.

This activity is supported by an educational grant from Takeda Pharmaceuticals USA, Inc.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This educational program is directed toward hematologists. Primary care physicians, nurse practitioners, physician assistants, and other health care professionals involved in the treatment of patients with VWD are also invited to participate.

Activity Overview

This online, on-demand virtual symposium brings together renowned experts with experience providing frontline care to patients with von Willebrand disease (VWD). In this educational program, these experts discuss the pathophysiology and clinical picture for the various VWD phenotypes; share insights on the application of the recently released 2021 consensus guidelines for VWD management; provide practical advice for handling challenging cases; and forecast future developments.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Discuss the genotypic and phenotypic presentation of VWD based on pathophysiology
  • Evaluate current treatment options for VWD
  • Develop management plans for patients with VWD
  • Apply shared decision-making principles to individualize treatment plans for patients with VWD based on presentation

Faculty

FACULTY_NAME

Jonathan C. Roberts, MD

Associate Medical Director
Associate Research Director
Bleeding & Clotting Disorders Institute
Assistant Professor of Pediatrics
University of Illinois College of Medicine
Peoria, IL

FACULTY_NAME

Robert F. Sidonio, Jr., MD, MSc

Pediatric Hematologist/Oncologist
Medical Director of Hemophilia,
Aflac Cancer & Blood Disorders Center
Children’s Healthcare of Atlanta
Associate Professor of Pediatrics,
Emory University School of Medicine
Atlanta, GA

FACULTY_NAME

Angela C. Weyand

Assistant Professor of Pediatrics
Division of Hematology and Oncology
University of Michigan Medical School
Ann Arbor, MI

 

Physician Accreditation Statement

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

Jonathan C. Roberts, MD

  • Grant Research Support: Takeda Pharmaceuticals USA
  • Consultant: Novo Nordisk, Octapharma, Pfizer, Sanofi, Takeda Pharmaceuticals USA
  • Speakers Bureau: Novo Nordisk, Octapharma, Sanofi, Takeda Pharmaceuticals USA

Robert F. Sidonio, Jr., MD, MSc

  • Grant Research Support: Pfizer, Sanofi, Takeda Pharmaceuticals USA
  • Consultant: Genentech, Sanofi

Angela C. Weyand

  • Grant Research Support: Investigator-initiated grant: Octapharma (Wil-31 PI VWD prophylaxis study), Takeda Pharmaceuticals USA (ATHN 9 VWD study), Takeda Pharmaceuticals USA (Bax 855 PUPs PI)
  • Consultant: Bayer Healthcare, BioMarin Pharmaceutical, HEMA Biologics, Novo Nordisk, Octapharma, uniQure

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.

Physicians’ Education Resource®, LLC (PER®), uses a blinded peer-review process. The peer reviewer discloses the following:

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Instructions for Participation and Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.
You may immediately download your certificate.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.